Retatrutide is a triple receptor agonist with simultaneous activity at the GIP, GLP-1, and glucagon receptors
It was designed to confirm the Phase 2b results and advance AOD 9604 toward regulatory approval
[16] Additionally, PCOS is associated with increased cardiovascular risk factors including dyslipidaemia, hypertension, and endothelial dysfunction
In this guide, we cut through the noise and give you a clear, side-by-side look at which therapy might work best for you
Whatever time and day you choose, stay consistent from week to week so that it becomes a regular part of your routine
Patients with diabetes require ongoing glucose monitoring, as tirzepatide may necessitate adjustments to other diabetes medications, particularly insulin or sulfonylureas, to prevent hypoglycemia